Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TBBK | PRCH |
|---|---|---|
| Price | $48.33 | $17.35 |
| Change today | ▼ 0.98% | ▲ 0.23% |
| Market cap | $1.97B | $1.97B |
| Return, 3 months | -26.3% | +18.2% |
| Return, year to date | -28.4% | +90.0% |
| Return, 1 year | -38.4% | +5.5% |
| P/E (TTM) | 9.1 | -133.5 |
| P/B | 2.8 | -166.8 |
| P/E percentile vs own 5y | 3rd | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +31.6% | +11.7% |
| Net profit growth (YoY) | +4.9% | -271.6% |
| Gross margin | – | 62.2% |
| Operating margin | – | -2.9% |
| Net margin | 34.5% | -10.0% |
| Return on equity | 29.6% | – |
| Analyst target vs. price | +66.9% | +13.5% |
| Analyst buy share | 100% | 83% |
| RSI (14) | 27 | 60 |
| 30-day volatility | 75.8% | 35.3% |
| Max drawdown, 1 year | -40.1% | -65.0% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
